Skip to main content
Top
Published in: Diagnostic Pathology 1/2011

Open Access 01-12-2011 | Research

Computerized texture analysis of atypical immature myeloid precursors in patients with myelodysplastic syndromes: an entity between blasts and promyelocytes

Authors: Joyce R Vido, Randall L Adam, Irene GH Lorand-Metze, Konradin Metze

Published in: Diagnostic Pathology | Issue 1/2011

Login to get access

Abstract

Background

Bone marrow (BM) blast count is an essential parameter for classification and prognosis of myelodysplastic syndromes (MDS). However, a high degree of cell atypias in bone marrow hemopoietic cells may be found in this group of clonal disorders, making it difficult to quantify precisely myeloblasts, and to distinguish them from promyelocytes and atypical immature myeloid precursors. Our aim was to investigate whether computerized image analysis of routine cytology would help to characterize these cells.

Methods

In May-Grünwald-Giemsa stained BM smears of 30 newly diagnosed MDS patients and 19 cases of normal BM, nuclei of blasts and promyelocytes were digitalized and interactively segmented. The morphological classification of the cells was done by consensus of two observers. Immature granulocytic precursors, which could not be clearly classified either as blasts or promyelocytes, were called "atypic myeloid precursors". Nuclear morphometry and texture features derived from the co-occurrence matrix and fractal dimension (FD) were calculated.

Results

In normal BM, when compared to myeloblasts, nuclei of promyelocytes showed significant increase in perimeter and local texture homogeneity and a decrease in form factor, chromatin gray levels, Haralick's entropy, inertia, energy, contrast, diagonal moment, cluster prominence, the fractal dimension according to Minkowski and its goodness-of-fit. Compared to normal myeloblast nuclei, the chromatin texture of MDS myeloblasts revealed higher local homogeneity and goodness-of-fit of the FD, but lower values of entropy, contrast, diagonal moment, and fractal dimension. The same differences were found between nuclei of normal promyelocytes and those of MDS. Nuclei of atypical myeloid precursors showed intermediate characteristics between those of blasts and promyelocytes according to the quantitative features (perimeter, form factor, gray level and its standard deviation), but were similar to promyelocytes according to the texture variables inertia, energy, contrast, diagonal moment, cluster prominence, and Minkowski's fractal dimension.

Conclusion

BM atypical immature myeloid precursors are difficult to be correctly classified in routine cytology. Although their cytoplasm is more similar to that of myeloblasts, computerized texture analysis indicates a nuclear chromatin remodeling more close to the promyelocyte, thus indicating an asynchronous intermediate maturation stage between blast and promyelocyte.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C: Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982, 51: 189-99.CrossRefPubMed Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C: Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982, 51: 189-99.CrossRefPubMed
2.
go back to reference Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett JM: International scoring system for evaluation in MDS. Blood. 1997, 89: 2079-88.PubMed Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett JM: International scoring system for evaluation in MDS. Blood. 1997, 89: 2079-88.PubMed
3.
go back to reference Haferlach T, Bacher U, Kern W, Schnittger S, Gassmann W, Haferlach C: A comprehensive approach to the diagnosis of MDS after triage by morphology towards cytogenetics and other techniques. Cancer Treat Rev. 2007, 33: S31-S41.CrossRef Haferlach T, Bacher U, Kern W, Schnittger S, Gassmann W, Haferlach C: A comprehensive approach to the diagnosis of MDS after triage by morphology towards cytogenetics and other techniques. Cancer Treat Rev. 2007, 33: S31-S41.CrossRef
4.
go back to reference Lorand-Metze I, Pinheiro MP, Ribeiro E, de Paula EV, Metze K: Factors influencing survival in myelodysplastic syndromes in a Brazilian population: Comparison of FAB and WHO classifications. Leuk Res. 2004, 28: 587-594. 10.1016/j.leukres.2003.11.001.CrossRefPubMed Lorand-Metze I, Pinheiro MP, Ribeiro E, de Paula EV, Metze K: Factors influencing survival in myelodysplastic syndromes in a Brazilian population: Comparison of FAB and WHO classifications. Leuk Res. 2004, 28: 587-594. 10.1016/j.leukres.2003.11.001.CrossRefPubMed
5.
go back to reference Ribeiro E, Lima CSP, Metze K, Lorand-Metze I: Flow cytometric analysis of the expression of Fas/Fasl in bone marrow CD34+ cells in myelodysplastic syndromes: relation to disease progression. Leuk & Lymph. 2004, 45: 309-313. 10.1080/10428190310001598044.CrossRef Ribeiro E, Lima CSP, Metze K, Lorand-Metze I: Flow cytometric analysis of the expression of Fas/Fasl in bone marrow CD34+ cells in myelodysplastic syndromes: relation to disease progression. Leuk & Lymph. 2004, 45: 309-313. 10.1080/10428190310001598044.CrossRef
6.
go back to reference Valent P, Horny HP, Bennett JM, Fonatsch C, Germing U, Greenberg P, Haferlach T, Haase D, Kolb HJ, Krieger O, Loken M, van de Loosdrecht A, Ogata K, Orfao A, Pfeilstöcker M, Rüter B, Sperr WR, Stauder R, Wells DA: Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference. Leuk Res. 2007, 31: 727-39. 10.1016/j.leukres.2006.11.009.CrossRefPubMed Valent P, Horny HP, Bennett JM, Fonatsch C, Germing U, Greenberg P, Haferlach T, Haase D, Kolb HJ, Krieger O, Loken M, van de Loosdrecht A, Ogata K, Orfao A, Pfeilstöcker M, Rüter B, Sperr WR, Stauder R, Wells DA: Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference. Leuk Res. 2007, 31: 727-39. 10.1016/j.leukres.2006.11.009.CrossRefPubMed
7.
go back to reference Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW: WHO classification of tumors of haematopoietic and lymphoid tissues. 2008, IARC press Lyon, France, 18-30. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW: WHO classification of tumors of haematopoietic and lymphoid tissues. 2008, IARC press Lyon, France, 18-30.
8.
go back to reference Goasguen JE, Bennett J, Bain B, Brunning R, Vallespi MT, Cox C, Mufti G: New definitions for blast cells in AML and MDS with validation by virtual microscopy [abstract]. Leuk Res. 2007, 31 (suppl 1): S25-CrossRef Goasguen JE, Bennett J, Bain B, Brunning R, Vallespi MT, Cox C, Mufti G: New definitions for blast cells in AML and MDS with validation by virtual microscopy [abstract]. Leuk Res. 2007, 31 (suppl 1): S25-CrossRef
9.
go back to reference Zini G, Bain B, Castoldi G, Cortez J, Csomor J, Faber E, Giagounidis A, Haferlach T, Kacirkova P, Lewandowski K, Liso V, Matutes E, Maynadiè M, Meletis J, Powit A, Ribeiro MC, Sreter L, Tichelli A, Vallespi T, van't Veer MB, Woessner S, Béné MC: European Leukemianet (ELN) project Diagnostic Platform (WP10): final results of the first study of the European Morphology Consensus Panel [abstract]. Blood. 2008, 112: 1645- Zini G, Bain B, Castoldi G, Cortez J, Csomor J, Faber E, Giagounidis A, Haferlach T, Kacirkova P, Lewandowski K, Liso V, Matutes E, Maynadiè M, Meletis J, Powit A, Ribeiro MC, Sreter L, Tichelli A, Vallespi T, van't Veer MB, Woessner S, Béné MC: European Leukemianet (ELN) project Diagnostic Platform (WP10): final results of the first study of the European Morphology Consensus Panel [abstract]. Blood. 2008, 112: 1645-
10.
go back to reference Wienert S, Beil M, Saeger K, Hufnagl P, Schrader T: Integration and acceleration of virtual microscopy as the key to successful implementation into the routine diagnostic process. Diagn Pathol. 2009, 9: 4-3 Wienert S, Beil M, Saeger K, Hufnagl P, Schrader T: Integration and acceleration of virtual microscopy as the key to successful implementation into the routine diagnostic process. Diagn Pathol. 2009, 9: 4-3
11.
go back to reference Izadi-Mood N, Yarmohammadi M, Ahmadi SA, Irvanloo G, Haeri H, Meysamie AP, Khaniki M: Reproducibility determination of WHO classification of endometrial hyperplasia/well differentiated adenocarcinoma and comparison with computerized morphometric data in curettage specimens in Iran. Diagn Pathol. 2009, 4: 10-10.1186/1746-1596-4-10.PubMedCentralCrossRefPubMed Izadi-Mood N, Yarmohammadi M, Ahmadi SA, Irvanloo G, Haeri H, Meysamie AP, Khaniki M: Reproducibility determination of WHO classification of endometrial hyperplasia/well differentiated adenocarcinoma and comparison with computerized morphometric data in curettage specimens in Iran. Diagn Pathol. 2009, 4: 10-10.1186/1746-1596-4-10.PubMedCentralCrossRefPubMed
12.
go back to reference Jondet M, Agoli-Agbo R, Dehennin L: Automatic measurement of epithelium differentiation and classification of cervical intraneoplasia by computerized image analysis. Diagn Pathol. 2010, 5: 7-10.1186/1746-1596-5-7.PubMedCentralCrossRefPubMed Jondet M, Agoli-Agbo R, Dehennin L: Automatic measurement of epithelium differentiation and classification of cervical intraneoplasia by computerized image analysis. Diagn Pathol. 2010, 5: 7-10.1186/1746-1596-5-7.PubMedCentralCrossRefPubMed
13.
go back to reference Roa-Peña L, Gómez F, Romero E: An experimental study of pathologist's navigation patterns in virtual microscopy. Diagn Pathol. 2010, 5: 71-10.1186/1746-1596-5-71.PubMedCentralCrossRefPubMed Roa-Peña L, Gómez F, Romero E: An experimental study of pathologist's navigation patterns in virtual microscopy. Diagn Pathol. 2010, 5: 71-10.1186/1746-1596-5-71.PubMedCentralCrossRefPubMed
14.
go back to reference Kayser K, Görtler J, Borkenfeld S, Kayser G: Interactive and automated application of virtual microscopy. Diagn Pathol. 2011, 6 (Suppl 1): S10-10.1186/1746-1596-6-S1-S10.PubMedCentralCrossRefPubMed Kayser K, Görtler J, Borkenfeld S, Kayser G: Interactive and automated application of virtual microscopy. Diagn Pathol. 2011, 6 (Suppl 1): S10-10.1186/1746-1596-6-S1-S10.PubMedCentralCrossRefPubMed
15.
go back to reference Baak JP, Snijders W, van Diermen B, van Diest PJ, Diepenhorst FW, Benraadt J: Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma. J Clin Oncol. 2003, 21: 4214-4221. 10.1200/JCO.2003.02.087.CrossRefPubMed Baak JP, Snijders W, van Diermen B, van Diest PJ, Diepenhorst FW, Benraadt J: Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma. J Clin Oncol. 2003, 21: 4214-4221. 10.1200/JCO.2003.02.087.CrossRefPubMed
16.
go back to reference Ferreira RC, de Matos PS, Adam RL, Leite NJ, Metze K: Application of the Minkowski-Bouligand fractal dimension for the differential diagnosis of thyroid follicular neoplasias. Cell Oncol. 2006, 28: 331-33.PubMed Ferreira RC, de Matos PS, Adam RL, Leite NJ, Metze K: Application of the Minkowski-Bouligand fractal dimension for the differential diagnosis of thyroid follicular neoplasias. Cell Oncol. 2006, 28: 331-33.PubMed
17.
go back to reference Mello MRB, Metze K, Adam RA, Pereira FG, Magalhães MG, Machado CG, Lorand-Metze I: Phenotypic subtypes of acute lymphoblastic leukemia associated with different nuclear chromatin texture. Anal Quant Cytol Histol. 2008, 30: 175-84. Mello MRB, Metze K, Adam RA, Pereira FG, Magalhães MG, Machado CG, Lorand-Metze I: Phenotypic subtypes of acute lymphoblastic leukemia associated with different nuclear chromatin texture. Anal Quant Cytol Histol. 2008, 30: 175-84.
18.
go back to reference Bedin V, Adam RL, Sá BCS, Landman G, Metze K: Fractal dimension is an independent prognostic factor for survival in melanoma. BMC Cancer. 2010, 10: 260-10.1186/1471-2407-10-260.PubMedCentralCrossRefPubMed Bedin V, Adam RL, Sá BCS, Landman G, Metze K: Fractal dimension is an independent prognostic factor for survival in melanoma. BMC Cancer. 2010, 10: 260-10.1186/1471-2407-10-260.PubMedCentralCrossRefPubMed
19.
go back to reference Metze K, Lorand-Metze I, Leite NJ, Adam RL: Goodness-of-fit of the fractal dimension as a prognostic factor. Cell Oncol. 2009, 31: 503-504.PubMed Metze K, Lorand-Metze I, Leite NJ, Adam RL: Goodness-of-fit of the fractal dimension as a prognostic factor. Cell Oncol. 2009, 31: 503-504.PubMed
20.
go back to reference Ferro DP, Falconi MA, Adam RL, Ortega MM, Lima CSP, de Souza CA, Lorand-Metze I, Metze K: Fractal Characteristics of May-Grünwald-Giemsa stained Chromatin are Independent Prognostic Factors for Survival in Multiple Myeloma. PLoS One. 2011, 6 (6): e20706-PubMedCentralCrossRefPubMed Ferro DP, Falconi MA, Adam RL, Ortega MM, Lima CSP, de Souza CA, Lorand-Metze I, Metze K: Fractal Characteristics of May-Grünwald-Giemsa stained Chromatin are Independent Prognostic Factors for Survival in Multiple Myeloma. PLoS One. 2011, 6 (6): e20706-PubMedCentralCrossRefPubMed
21.
go back to reference Mello MLS, Vidal BC, Russo IH, Lareef MH, Russo J: DNA content and chromatin texture of human breast epithelial cells transformed with 17-beta-estradiol and the estrogen antagonist ICI 182,780 as assessed by image analysis. Mutat Res-Rev Mutat. 2007, 617: 1-7.CrossRef Mello MLS, Vidal BC, Russo IH, Lareef MH, Russo J: DNA content and chromatin texture of human breast epithelial cells transformed with 17-beta-estradiol and the estrogen antagonist ICI 182,780 as assessed by image analysis. Mutat Res-Rev Mutat. 2007, 617: 1-7.CrossRef
22.
go back to reference Serrano D, Gandini S, Mariani L, Bonanni B, Santinelli A, Guerrieri-Gonzaga A, Pelosi G, Cassano E, Montironi R, Decensi A: Computer-assisted image analysis of breast fine needle aspiration in a randomized chemoprevention trial of fenretinide vs. placebo in HRT users. Breast. 2008, 17: 91-97. 10.1016/j.breast.2007.07.038.CrossRefPubMed Serrano D, Gandini S, Mariani L, Bonanni B, Santinelli A, Guerrieri-Gonzaga A, Pelosi G, Cassano E, Montironi R, Decensi A: Computer-assisted image analysis of breast fine needle aspiration in a randomized chemoprevention trial of fenretinide vs. placebo in HRT users. Breast. 2008, 17: 91-97. 10.1016/j.breast.2007.07.038.CrossRefPubMed
23.
go back to reference Kortenhorst MSQ, Isharwal S, Van Diest PJ, Chowdhury WH, Marlow C, Carducci MA, Rodriguez R, Veltri RW: Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo. Mol Cancer Ther. 2009, 8: 802-08. 10.1158/1535-7163.MCT-08-1076.PubMedCentralCrossRefPubMed Kortenhorst MSQ, Isharwal S, Van Diest PJ, Chowdhury WH, Marlow C, Carducci MA, Rodriguez R, Veltri RW: Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo. Mol Cancer Ther. 2009, 8: 802-08. 10.1158/1535-7163.MCT-08-1076.PubMedCentralCrossRefPubMed
24.
go back to reference Yatouji S, El-Khoury V, Trentesaux C, Trussardi-Regnier A, Benabidet R, Bontems F, Dufer J: Differential modulation of nuclear texture, histone acetilation and MDR1 gene expression in human drug-sensitive and resistant OV1 cell lines. Int J Oncol. 2007, 30: 1003-09.PubMed Yatouji S, El-Khoury V, Trentesaux C, Trussardi-Regnier A, Benabidet R, Bontems F, Dufer J: Differential modulation of nuclear texture, histone acetilation and MDR1 gene expression in human drug-sensitive and resistant OV1 cell lines. Int J Oncol. 2007, 30: 1003-09.PubMed
25.
go back to reference Kayser K, Hoshang SA, Metze K, Goldmann T, Vollmer E, Radziszowski D, Kosjerina Z, Mireskandari M, Kayser G: Texture and object-related automated information analysis in histological still images of various organs. Anal Quant Cytol Histol. 2008, 30: 323-35.PubMed Kayser K, Hoshang SA, Metze K, Goldmann T, Vollmer E, Radziszowski D, Kosjerina Z, Mireskandari M, Kayser G: Texture and object-related automated information analysis in histological still images of various organs. Anal Quant Cytol Histol. 2008, 30: 323-35.PubMed
26.
go back to reference Metze K: Fractal dimension of chromatin and cancer prognosis. Epigenomics. 2010, 2: 601-604. 10.2217/epi.10.50.CrossRefPubMed Metze K: Fractal dimension of chromatin and cancer prognosis. Epigenomics. 2010, 2: 601-604. 10.2217/epi.10.50.CrossRefPubMed
27.
go back to reference Metze K, Adam RL, Leite NJ: Changes of texture features due to image compression. Diagn Pathol. 2010, 5 (Suppl 1): S15-10.1186/1746-1596-5-S1-S15.CrossRef Metze K, Adam RL, Leite NJ: Changes of texture features due to image compression. Diagn Pathol. 2010, 5 (Suppl 1): S15-10.1186/1746-1596-5-S1-S15.CrossRef
28.
go back to reference Metze K, Adam RL, Ferreira RC: Robust variables in texture analysis. Pathology. 2010, 42: 609-610. 10.3109/00313025.2010.508794.CrossRefPubMed Metze K, Adam RL, Ferreira RC: Robust variables in texture analysis. Pathology. 2010, 42: 609-610. 10.3109/00313025.2010.508794.CrossRefPubMed
29.
go back to reference Adam RL, Silva RC, Pereira FG, Leite NJ, Lorand-Metze I, Metze K: The fractal dimension of nuclear chromatin as a prognostic factor in acute precursor B lymphoblastic leukemia. Cell Oncol. 2006, 28: 55-59.PubMed Adam RL, Silva RC, Pereira FG, Leite NJ, Lorand-Metze I, Metze K: The fractal dimension of nuclear chromatin as a prognostic factor in acute precursor B lymphoblastic leukemia. Cell Oncol. 2006, 28: 55-59.PubMed
30.
go back to reference Melnick AM: Epigenetics in AML. Best Pract Res Clin Haematol. 2010, 23: 463-468. 10.1016/j.beha.2010.09.017.CrossRefPubMed Melnick AM: Epigenetics in AML. Best Pract Res Clin Haematol. 2010, 23: 463-468. 10.1016/j.beha.2010.09.017.CrossRefPubMed
31.
go back to reference De Capoa A, Febbo FR, Giovannelli F, Niveleau A, Zardo G, Marenzi S, Caiafa P: Reduced levels of poly (ADP-ribosyl)ation result in chromatin compaction and hypermethylation as shown by cell-by-cell computer-assisted quantitative analysis. FASEB J. 1999, 13: 89-93.PubMed De Capoa A, Febbo FR, Giovannelli F, Niveleau A, Zardo G, Marenzi S, Caiafa P: Reduced levels of poly (ADP-ribosyl)ation result in chromatin compaction and hypermethylation as shown by cell-by-cell computer-assisted quantitative analysis. FASEB J. 1999, 13: 89-93.PubMed
32.
go back to reference Reis-Alves SC, Traina I, Saad ST, Metze K, Lorand-Metze I: The impact of several phenotypic features at diagnosis on survival of patients with myelodysplastic syndromes. Neoplasma. 2010, 57: 530-536. 10.4149/neo_2010_06_530.CrossRefPubMed Reis-Alves SC, Traina I, Saad ST, Metze K, Lorand-Metze I: The impact of several phenotypic features at diagnosis on survival of patients with myelodysplastic syndromes. Neoplasma. 2010, 57: 530-536. 10.4149/neo_2010_06_530.CrossRefPubMed
33.
go back to reference Bernasconi P: Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review. Br J Haematol. 2008, 142: 695-708. 10.1111/j.1365-2141.2008.07245.x.CrossRefPubMed Bernasconi P: Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review. Br J Haematol. 2008, 142: 695-708. 10.1111/j.1365-2141.2008.07245.x.CrossRefPubMed
34.
go back to reference Lorand-Metze I, Ribeiro E, Lima CSP, Batista LS, Metze K: Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders. Leuk Res. 2007, 31: 147-155. 10.1016/j.leukres.2006.04.010.CrossRefPubMed Lorand-Metze I, Ribeiro E, Lima CSP, Batista LS, Metze K: Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders. Leuk Res. 2007, 31: 147-155. 10.1016/j.leukres.2006.04.010.CrossRefPubMed
35.
go back to reference Vollmer RT: Blast counts in bone marrow aspirate smears. Am J Clin Pathol. 2009, 131: 183-88. 10.1309/AJCPBAYNCU35ZGZG.CrossRefPubMed Vollmer RT: Blast counts in bone marrow aspirate smears. Am J Clin Pathol. 2009, 131: 183-88. 10.1309/AJCPBAYNCU35ZGZG.CrossRefPubMed
36.
go back to reference Mufti GJ, Bennett J, Goasguen J, Bain BJ, Baumann I, Brunning R, Cazzola M, Fenaux P, Germing U, Hellström-Lindberg E, Jinnai I, Manabe A, Matsuda A, Niemeyer CM, Sanz G, Tomonaga M, Vallespi T, Yoshimi A: Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica. 2008, 93: 1712-1717. 10.3324/haematol.13405.CrossRefPubMed Mufti GJ, Bennett J, Goasguen J, Bain BJ, Baumann I, Brunning R, Cazzola M, Fenaux P, Germing U, Hellström-Lindberg E, Jinnai I, Manabe A, Matsuda A, Niemeyer CM, Sanz G, Tomonaga M, Vallespi T, Yoshimi A: Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica. 2008, 93: 1712-1717. 10.3324/haematol.13405.CrossRefPubMed
37.
go back to reference Schanz J, Steidl C, Fonatsch C, Pfeilstöcker M, Nösslinger T, Tuechler H, Valent P, Hildebrandt B, Giagounidis A, Aul C, Lübbert M, Stauder r, Krieger O, Garcia-Manero G, Kantarjian H, Germing U, Haase D, Estey E: Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system. J Clin Oncol. 2011, 29: 1963-1970. 10.1200/JCO.2010.28.3978.CrossRefPubMed Schanz J, Steidl C, Fonatsch C, Pfeilstöcker M, Nösslinger T, Tuechler H, Valent P, Hildebrandt B, Giagounidis A, Aul C, Lübbert M, Stauder r, Krieger O, Garcia-Manero G, Kantarjian H, Germing U, Haase D, Estey E: Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system. J Clin Oncol. 2011, 29: 1963-1970. 10.1200/JCO.2010.28.3978.CrossRefPubMed
Metadata
Title
Computerized texture analysis of atypical immature myeloid precursors in patients with myelodysplastic syndromes: an entity between blasts and promyelocytes
Authors
Joyce R Vido
Randall L Adam
Irene GH Lorand-Metze
Konradin Metze
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2011
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/1746-1596-6-93

Other articles of this Issue 1/2011

Diagnostic Pathology 1/2011 Go to the issue